- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Shilpa Therapeutics covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (93), financial health (5), director (95) and company-foundation signals.
- Operating for 22+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Loss-making in FY 2023.
- Negative net worth - capital eroded by losses.
- 2 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Shilpa Therapeutics
Shilpa Therapeutics is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U24239KA2004PTC176079). Business overview includes Pharma (Drug Formulation & Development), incorporated on April 02, 2004 (22+ years old), headquartered in Raichur, Karnataka, India. The company is currently Active with Active Compliant compliance status.
- Location Shilpa House, #12-6-214/A1, Hyderabad Road, Raichur, Karnataka - 584135
- Website shilpatherapeutics.com
Financial Performance of Shilpa Therapeutics
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Shilpa Therapeutics (2)
Charges of Shilpa Therapeutics
| Lender | Amount | Status |
|---|---|---|
|
Citi Bank N.A.
Creation Date: 16 Apr 2020 |
25.00 cr | Closed |
|
Citi Bank N.A.
Creation Date: 16 Apr 2020 |
5.00 cr | Closed |
|
Axis Bank Limited
Creation Date: 19 Dec 2016 |
2.00 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
